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Background: It was reported that autonomic nervous system function is altered in subjects 
with chronic obstructive pulmonary disease (COPD). We evaluated short- and long-term fractal 
exponents of heart rate variability (HRV) in COPD subjects.
Patients and methods: We analyzed data from 30 volunteers, who were divided into 
two groups according to spirometric values: COPD (n = 15) and control (n = 15). For analysis 
of HRV indices, HRV was recorded beat by beat with the volunteers in the supine position 
for 30 minutes. We analyzed the linear indices in the time (SDNN [standard deviation of 
normal to normal] and RMSSD [root-mean square of differences]) and frequency domains 
(low   frequency [LF], high frequency [HF], and LF/HF), and the short- and long-term fractal 
exponents were obtained by detrended fluctuation analysis. We considered P , 0.05 to be a 
significant difference.
Results: COPD patients presented reduced levels of all linear exponents and decreased short-
term fractal exponent (alpha-1: 0.899 ± 0.18 versus 1.025 ± 0.09, P = 0.026). There was no sig-
nificant difference between COPD and control groups in alpha-2 and alpha-1/alpha-2 ratio.
Conclusion: COPD subjects present reduced short-term fractal correlation properties of HRV , 
which indicates that this index can be used for risk stratification, assessment of systemic disease 
manifestations, and therapeutic procedures to monitor those patients.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow 
obstruction, which is not fully reversible,1,2 and significant systemic manifestations 
such as nutritional depletion, structural and functional changes of respiratory and 
peripheral muscles, and arrhythmias.3 Autonomic nervous system (ANS) dysfunction 
is also reported in COPD patients.4–6 This may represent an important negative factor, 
as the ANS regulates internal functions of the body.
One method to evaluate the ANS function is the analysis of heart rate   variability 
(HRV), the conventionally accepted term to describe the fluctuations in the intervals 
between consecutive heartbeats (RR intervals), which are indicated to influence the 
sinusal node.7 Previous studies indicate that COPD subjects present decreased HRV at 
rest compared with control subjects at the same age.8–10 Those studies regard specific 
changes of autonomic function in COPD-assessed HRV through linear methods in 
the time and frequency domains. However, to the best of our   knowledge, no previous 
investigation has employed   nonlinear methods to evaluate HRV in COPD patients.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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HRV analysis using nonlinear methods has been   receiving 
attention. There is evidence that mechanisms involved in 
cardiovascular regulation likely interact between each other 
in a nonlinear fashion.11–13 One method used for this purpose 
is detrended fluctuation analysis (DFA), which quantifies 
the presence or absence of fractal correlation properties 
of the RR intervals.11 According to Tulppo et al14,15 fractal 
indices are able to detect slight changes in the dynamics 
of RR intervals better than conventional spectral analyses. 
Moreover,   impairment of fractal correlation properties 
of short- and long-term dynamics of HRV helps clinical 
  professionals to detect autonomic dysfunction and avoid 
disease development.
Based on the above considerations, we hypothesized that 
COPD patients would present altered heart rate dynamics. 
Therefore, this investigation was undertaken to evaluate short- 
and long-term fractal exponents of HRV in COPD subjects.
Methods
Population
We selected 15 patients (10 male) with a medical diagnosis of 
COPD, confirmed through spirometric test according to the 
Global Initiative for Chronic Obstructive Pulmonary Disease 
(GOLD),1 who were under treatment at the Centro de Estudos 
e Atendimento em Fisioterapia e Reabilitação da Faculdade de 
Ciências e Tecnologia, Universidade Estadual Paulista (Presi-
dente Prudente, Brazil). When unhealthy   conditions were 
reported, except for hypertension, the subject was not included 
in the sample. Furthermore, we excluded current smokers, 
individuals who were taking medication that influences the 
cardiac autonomic modulation, patients who presented COPD 
exacerbation in the last 2 months prior to the experimental 
protocol, and those who presented a restrictive pattern or no 
reproducible curves during the spirometric tests. The control 
group consisted of 15 healthy subjects (8 male), without 
diagnosis of COPD and who presented normal   spirometric 
values. Group profiles are presented in Table 1.
All volunteers were informed about the procedures and 
objectives of the study, and on agreement they signed a con-
sent letter. All work procedures were approved by the Ethics 
Committee in Research of our university (protocol number 
246/08) and followed Resolution 196/96 of the National 
Health Council of October 10, 1996.
Initial evaluation
Before beginning the experimental procedure, we collected 
the following information: age, gender, height, weight, body 
mass index (BMI), heart rate (HR), systolic blood pressure 
(SBP), and diastolic blood pressure (DBP). Anthropometric 
measurements were obtained following the standard recom-
mendations proposed by Lohman et al.16 BMI was calculated 
using the following formula: weight (kg)/height (m2).
experimental protocol
Data  were  collected  under  controlled  temperature 
(21°C–24°C) and humidity (50%–60%), and volunteers 
were instructed to avoid consuming alcohol and caffeine 
for 24 hours before evaluation. Data were collected between 
8 a.m. and 11 a.m. in order to minimize the interference of 
circadian rhythm. All procedures necessary for the data col-
lection were explained to the individuals, and the subjects 
were instructed to remain at rest and to avoid talking during 
the data collection.
After the initial evaluation the heart monitor strap 
was placed on each subject’s thorax over the distal third 
of the sternum. The HR receiver (Polar S810i monitor, 
Polar Electro OY, Kempele, Finland) was placed on the 
wrist. This   equipment has been previously validated for 
Table 1 Anthropometric and spirometric profile, baseline heart 
rate, and blood pressure of the COPD and control groups
Variable COPDa Controla P
Age (years) 73.93 ± 6.61 
[70.28–77.59]
68.73 ± 7.27 
[64.70–72.76]
0.050
Weight (kg) 65.46 ± 9.05 
[60.45–70.47]
69.30 ± 12.9 
[62.13–76.41]
0.358
height (cm) 1.63 ± 0.09 
[1.51–1.75]
1.58 ± 0.09 
[1.44–1.74]
0.112
BMI (kg/m²) 24.47 ± 2.85 
[22.89–26.05]
27.73 ± 4.88 
[25.03–30.43]
0.036
FVC (%) 81.59 ± 18.60 
[58.0–109.3]
97.18 ± 14.62 
[73.4–131.6]
0.0164
FeV1 (%) 51.69 ± 16.32 
[31–88]
97.18 ± 14.62 
[73.4–131.60]
,0.0001
FeV1/FVC 47.42 ± 10.8 (47.0) 
[41.43–53.40]
79.36 ± 11.4 (80.0) 
[73.06–85.66]
,0.0001
PeF (L/s) 3.36 ± 1.5 (3.53) 
[2.56–4.17]
6.38 ± 2.16 (6.17) 
[5.18–7.57]
0.0003
hr (bpm) 70.73 ± 10.9 
[64.6–76.8]
65.93 ± 7.6 
[61.71–70.15]
0.092
sBP (mm hg) 127.8 ± 18.7 (130) 
[90–160]
132.8 ± 11.13 (130) 
[118–160]
0.5328
DBP (mm hg) 74.0 ± 12.07 (70) 
[58–100]
81.73 ± 9.96 (80) 
[76.2–87.2]
0.0766
Note: aMean ± standard deviation (median) [confidence interval 95%].
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass 
index; FVC, forced vital capacity; FeV1, forced expiratory volume at the first second; 
PEF,  peak  expiratory  flow;  HR,  heart  rate;  SBP,  systolic  blood  pressure;  DBP, 
diastolic blood pressure.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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beat-by-beat measurements and for HRV analysis.17–20 The 
subjects were placed in the dorsal decubitus position on a 
cushion and remained at rest with spontaneous breathing 
for 30 minutes.
After the experimental procedures, we performed 
  spirometric tests to identify and stratify the degree of 
  bronchial obstruction. We used the Spirobank spirometer 
and a computer equipped with WinspiroPRO 1.1.6 software 
(Medical International Research, Rome, Italy). Data analysis 
was done according to the criteria described by the Guidelines 
for Pulmonary Function Tests.21
Linear index of hrV evaluation
HRV was recorded beat by beat through the monitoring 
process at a sampling rate of 1000 Hz. During the period of 
higher signal stability, an interval of 5 minutes was selected, 
and series with more than 256 RR intervals were used for 
analysis,7 following digital filtering complemented with 
manual filtering for the elimination of premature ectopic 
beats and artifacts. Only series with more than 95% sinus 
rhythm were included in the study.13
To analyze HRV in the frequency domain, the low 
frequency (LF) (0.04–0.15 Hz) spectral component, which 
indicates both sympathetic and parasympathetic activity,7,20 
and high frequency (HF) (0.15–0.40 Hz) spectral component, 
which indicates parasympathetic activity,7,20 were used,2 
as well as the ratio between these components (LF/HF). 
The spectral analysis was calculated using the Fast Fourier 
Transform algorithm.7,20 Analysis in the time domain was 
performed by means of SDNN (standard deviation of normal-
to-normal RR intervals) and RMSSD (root-mean square of 
differences between adjacent normal RR intervals in a time 
interval). For analysis of linear indexes in the time and fre-
quency domains, we used the software HRV analysis.22
Fractal analysis of hrV
For the analysis of the fractal properties of the HR, DFA 
was applied to a time series of the RR intervals. This 
method is a modification of mean square root analysis of a 
random walk and is based on the analysis of fluctuations in 
the data following the removal of trends in the integrated 
time series,23 which allows the detection of intrinsic self-
similarity   embedded in the nonstationary time series.24 We 
calculated the short-term fractal exponent (alpha-1), which 
corresponds to a period of 4–11 beats; long-term fractal 
exponent (alpha-2), which represents periods longer than 
11 beats;25 and the alpha-1/alpha-2 ratio.
A software program available at PhysioNet (http://
www.physionet.org) – an online forum that fuses records of 
  biomedical signals and software programs for the analysis 
of these signals – was used for the DFA.26
statistical analysis
A Shapiro–Wilk test was used to evaluate the normality of 
the data. The nonpaired Student’s t-test was applied to verify 
  differences between parametric variables (age, weight, height, 
BMI, forced vital capacity [FVC], HR, SBP, DBP, HFms², 
RMSSD, SDNN, alpha-1, alpha-2, and alpha-1/alpha-2). The 
Mann–Whitney test was used to verify differences between 
nonparametric variables (LFms², LF/HF, forced expiratory 
volume in the first second [FEV1], FEV1/FVC, and peak 
expiratory flow [PEF]). Differences were considered sig-
nificant when the probability of a Type I error was lower 
than 5% (P , 0.05).
The calculation of the study power (StatMate GraphPad 
Software version 2.00 for Windows, GraphPad Software, San 
Diego, CA, USA) with the number of subjects analyzed and 
significance level of 5% (two-tailed test) confirmed a power 
higher than 80% to detect differences between the variables.
Results
Table 1 presents anthropometric measurements, spirometric 
values, HR, SBP, and DBP at rest in COPD and control 
groups. We observed that BMI, FVC, FEV1, FEV1/FVC, and 
PEF were significantly lower in COPD subjects compared 
with the control group. There was no significant difference 
between the groups regarding HR, SBP, and DBP at rest.
Table 2 shows the values of alpha-1, alpha-2, and the ratio 
alpha-1/alpha-2 in COPD and control groups. We noted that 
the COPD group presented lower values of alpha-1 compared 
with the control group. However, we did not report   differences 
between the COPD and control groups with respect to alpha-2 
and the ratio alpha-1/alpha-2 values.
Table 2 Values of alpha-1, alpha-2, and alpha-1/alpha-2 ratio in 
the COPD and control groups
Variable COPDa Controla P
Alpha-1 0.9 ± 0.18 
[0.79–1.00]
1.02 ± 0.09 
[0.97–1.07]
0.026
Alpha-2 0.92 ± 0.11 
[0.86–0.98]
0.91 ± 0.12 
[0.85–0.98]
0.853
Alpha-1/alpha-2 0.99 ± 0.27 
[0.84–1.14]
1.13 ± 0.13 
[1.05–1.20]
0.069
Note: aMean ± standard deviation [confidence interval 95%].
Abbreviation: COPD, chronic obstructive pulmonary disease.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Table 3 displays the values of the LF and HF indices in 
normalized units and ms2 as well as the LF/HF ratio in COPD 
and control groups. There was reduction of all indices in 
COPD patients compared with control subjects.
Discussion
The results of the present study suggest that there is a loss or 
disarrangement of the properties of short-term fractal correla-
tions of HRV associated with a reduction in both sympathetic 
and parasympathetic activity in COPD subjects.
According to Tulppo et al15 and Acharya et al,24 in rela-
tion to exponents obtained by the DFA, values close to 1 are 
indicative of a fractal system, whereas values close to 0.5 
are associated with random signal, where there is no cor-
relation between the values. Therefore, our results indicate 
that COPD patients exhibit dynamic changes in HR toward 
a more dynamic random profile, which indicates a condition 
of loss of chaos.
Under conditions where the action of sympathetic 
and parasympathetic components of the ANS on HR is 
organized in a reciprocal behavior, ie, an increased activ-
ity of a system is accompanied by a decrease of another, 
there is a strong short-term fractal correlation expressed 
by   increasing the value of alpha-1.14,27 Notwithstanding 
conditions in which there is increased activity of both 
ANS components (  sympathetic and parasympathetic), 
loss of short-term HR fractal organization was noted, 
which decreased the value of alpha-1.15,28,29 According to 
our study, the analysis of linear indices in the time and 
frequency domains in ms2, as well as the ratio between 
these two components (LF/HF), in COPD patients showed 
reduction of both parasympathetic and   sympathetic com-
ponents of the ANS compared with the   control group. 
Furthermore, reduced activity of sympathetic and para-
sympathetic components of the ANS in elderly patients 
with COPD compared with control subjects at similar age 
at rest and supine position was observed previously.4–6 
Taken together, our findings and previous investigations 
suggest that the reduction of alpha-1 reflects a decrease 
in both ANS component activities.
The loss of short-term fractal correlation property that 
we found in COPD subjects is related to the occurrence 
of several adverse clinical events such as heart failure23,25 
and acute myocardial infarction.30 In addition, reduction 
of alpha-1 was observed before spontaneous onset of atrial 
fibrillation in patients without structural heart disease27 
associated with vulnerability to ventricular tachycardia23,30 
and ventricular fibrillation.31 Exponent values lower than 
0.85 were observed in patients with cardiovascular disease 
associated with increased mortality rate.28–30 These values 
are close to those found in our study (alpha-1 = 0.899) in 
COPD patients.
Our investigation suggests that COPD subjects present 
autonomic dysfunction, characterized by loss of short-term 
fractal correlation of HRV and reductions of sympathetic 
and parasympathetic activity. It corroborates the importance 
of the use of nonlinear dynamics analysis in the prognostic 
assessment of morbid states, due to its ability to evaluate 
the degree of loss of the patient’s homeostatic behavior, 
considering the whole and not only the severity of the dis-
eases alone.
Nonlinear methods of HRV analysis describe   complex 
fluctuations in heart rhythm and are able to separate 
  structures with nonlinear behavior in heartbeat time series 
more adequately than linear methods.12 They enable a better 
discrimination between individuals with normal and altered 
physiology,13 as well as a better understanding of the nature 
of the complex dynamic systems that occur in the human 
body in both health and sickness.32
In relation to long-term exponents (alpha-2) and alpha-1/
alpha-2 ratio, there was no difference between the COPD 
and control groups. Our findings suggest that COPD 
patients present autonomic dysfunction characterized by 
loss of short-term fractal correlation of HRV associated with 
sympathetic and parasympathetic activity reduction. Thus, 
interventions that may restore fractal dynamic properties of 
HR and increase HRV may have important clinical implica-
tions, and the performance of physical exercise programs 
should be emphasized. In a study that evaluated the effect of 
resistance training in healthy adults, Heffernan et al33 found 
improvement of fractal dynamic properties of HR, whereas 
Borghi-Silva et al4 investigated the effects of aerobic training 
Table 3 Linear index values of heart rate variability (frequency 
and time domains) in the COPD and control groups
Variable COPDa Controla P
LFms2 28.80 ± 24.48 (20.0) 
[15.24–42.36]
130.00 ± 131.51 (88.0) 
[57.17–202.83]
0.0007
hFms2 18.93 ± 9.89 
[13.46–24.41]
52.5 ± 38.3 
[31.33–73.74]
0.005
rMssD 11.23 ± 3.48 
[9.30–13.16]
18.93 ± 7.48 
[14.78–23.07]
0.002
sDnn 14.13 ± 5.03 
[6–24]
25.4 ± 9.5 
[11–49]
0.0004
Note: aMean ± standard deviation (median) [confidence interval 95%].
Abbreviations: COPD, chronic obstructive pulmonary disease; LF, low frequency; 
hF,  high  frequency;  ms,  miliseconds;  rMssD,  root-mean  square  of  differences 
between adjacent normal rr intervals in a time interval; sDnn, standard deviation 
of normal-to-normal rr intervals.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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on autonomic cardiac regulation in COPD subjects and also 
found changes reflected by improvement of HRV indices in 
the time and frequency domains.
Our research presents a couple of points that should be 
addressed. First, both groups presented hypertensive patients; 
however, basal HR, SBP, and DBP were not significantly dif-
ferent between the groups. Second, COPD subjects presented 
different degrees of obstruction. Nevertheless, Camillo et al5 
have shown that COPD severity is not significantly related 
to HRV indices.
To the best of our knowledge, our findings are the first to 
evidence reduced alpha-1, the short-term fractal exponent, in 
COPD subjects. Our findings are relevant, as they indicate 
that these indices, obtained by a noninvasive and inexpensive 
method, may be useful both for clinical manifestations of 
systemic disease and for risk stratification and monitoring of 
therapeutic procedures performed with these patients.
In conclusion, COPD subjects present reduced short-
term fractal correlation of HRV , indicating sympathetic and 
parasympathetic activity reduction.
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